What are the irritative (storage) and obstructive (voiding) symptoms of benign prostatic hyperplasia?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: October 19, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

BPH Symptoms: Irritative (Storage) and Obstructive (Voiding)

Lower urinary tract symptoms (LUTS) in men with benign prostatic hyperplasia are divided into two main categories: storage symptoms (previously called "irritative") and voiding symptoms (previously called "obstructive"), though modern terminology emphasizes the functional phase rather than the outdated irritative/obstructive labels 1, 2.

Storage Symptoms (Irritative)

Storage symptoms occur during the bladder filling/storage phase and include 1, 2:

  • Daytime urinary frequency - voiding more than 8 times per day
  • Nocturia - waking at night one or more times to urinate (prevalence approaches 90% in BPH patients) 3
  • Urgency - sudden compelling desire to void that is difficult to defer
  • Urge incontinence - involuntary urine leakage associated with urgency

Important clinical note: While voiding symptoms are more common in BPH patients, storage symptoms are typically more bothersome to patients and have greater impact on quality of life 4. Nocturia, despite being highly prevalent, is often not considered as serious by patients as other symptoms like urge incontinence 3.

Voiding Symptoms (Obstructive)

Voiding symptoms occur during the emptying phase and include 1, 2, 5:

  • Hesitancy - difficulty initiating urination
  • Weak urinary stream - reduced force and caliber of stream
  • Intermittency - stream stops and starts during voiding
  • Straining - need to push or apply abdominal pressure to void
  • Prolonged voiding - increased time to complete urination
  • Incomplete emptying sensation - feeling that bladder has not fully emptied

Post-Micturition Symptoms

Additional symptoms occurring after voiding include 5, 6:

  • Post-void dribbling - involuntary urine loss immediately after completing urination
  • Sensation of incomplete bladder emptying

Critical Terminology Clarification

The guidelines strongly emphasize that terms like "symptomatic BPH," "BPH patient," or "BPH treatment" are imprecise and should be avoided 1, 7. The more accurate framework recognizes that:

  • BPH = histologic diagnosis only (tissue proliferation)
  • Benign prostatic enlargement (BPE) = enlarged prostate gland
  • Benign prostatic obstruction (BPO) = proven obstruction from enlarged prostate
  • LUTS = the actual symptoms patients experience

LUTS may or may not be associated with BPH, BPE, or BPO, as symptoms can arise from bladder dysfunction, neurological conditions, or other causes 1, 2.

Clinical Assessment Framework

When evaluating these symptoms, the International Prostate Symptom Score (IPSS) divides questions into voiding symptoms (questions 1,3,5,6) and storage symptoms (questions 2,4,7) 8. The modified IPSS (mIPSS) shows stronger correlation with objective uroflowmetry parameters and may be more reliable for assessment 8.

Frequency-volume charts are specifically recommended when nocturia is a bothersome symptom to distinguish between nocturnal polyuria (excessive nighttime urine production) and reduced bladder capacity 1.

Related Questions

How is benign prostatic hyperplasia diagnosed in a male patient over 50 with lower urinary tract symptoms?
What is the best course of treatment for a 71-year-old male with Benign Prostatic Hyperplasia (BPH) and Lower Urinary Tract Symptoms (LUTS) who is currently taking tamsulosin (flomax) 0.4mg twice daily, presenting with weak urinary stream, intermittent urinary incontinence, urgency, and nocturia, and has multiple comorbidities including type 2 diabetes, Coronary Artery Disease (CAD), Congestive Heart Failure (CHF), Chronic Obstructive Pulmonary Disease (COPD), hypertension, and Chronic Kidney Disease (CKD) stage 2?
What is the appropriate management for a 70‑year‑old male with benign prostatic hyperplasia who presents with cloudy, foul‑smelling urine, urinary frequency, urgency, and fever?
What is the recommended treatment for symptomatic benign prostatic hyperplasia in an adult male?
Can masturbation prevent benign prostatic hyperplasia?
Is a prolonged cough with scant sputum, occurring after a 3‑day course of mebendazole, likely related to the drug and how should it be managed?
What are the approved indications, dosing regimen, eligibility criteria, and common adverse effects of Penpulimab (anti‑PD‑1 monoclonal antibody)?
What are the classes of anticoagulants, their indications, contraindications, and half‑lives?
What evaluation and management CPT code should be used for an established patient seen for impacted cerumen and otitis media with perforation of the tympanic membrane?
Why do my toes feel numb when I wake up in the morning?
What is the appropriate treatment for a patient with asthma who has restrictive lung disease and CT findings of mild hyperinflation with bilateral air trapping?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.